Skip to content

CARDIOMED

Active Private limited companyfounded 2002active for 24 yearsCharles-Maurice Wiserplein 15, 1040 EtterbeekKBO/BCE: BE 0477.355.014

Lifetime

19 annual accounts with figures on one time axis, 23 filings since 2003
peak of €198,498 in 2013
€101,005▼ 2.7%
peak of €123,704 in 2013
€42,904▼ 26.8%
peak of €233,876 in 2024
€182,981▼ 21.8%
€25,410▼ 1.1%
Board1 name since 2020
1 director
Documentsfilings and deeds
04-02-20264 days late
2025micro format
Result from €58,649 to €42,904Dividend €93,800Equity from €233,876 to €182,981Cash from €37,175 to €50,816

Key points

from the 2025 annual accounts

Equity

€182,981 ▼ 21.8%
233,8762024+42,904Profit-93,800Dividend182,9812025

CARDIOMED paid out €93,800 in dividends. That is 219% of the 2025 profit.

Filings

23 annual accounts since 2003
deadline20102020

Five of the last ten came late. The 2019 accounts came in latest, 28 days after the end of the period.

Position in the sector

87.8%

Higher solvency than 86% of companies in head offices and management consultancy. Sector median 55.5% · 41,270 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as CARDIOMED has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for CARDIOMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

changes role from manager to director Director discharge: (manager) · General meeting of 19-10-2023 · Gazette deed
appointed as manager General meeting of 15-05-2020 · Gazette deed
First establishment Charles-Maurice Wiserplein 15, Etterbeek
Incorporation published on 30-04-2002 · Gazette deed
All 35 events

Comparable companies

same main activity, similar in size and age
Company
CARDIOMED Etterbeek €208,391 €101,005 87.8% -
VIGILANT Watermael-Boitsfort €192,761 €84,590 80.7% -
KAUL & ASSOCIATES Watermael-Boitsfort €219,813 €84,089 2.6% -
AREMA Ixelles €171,924 €92,508 61.4% -
CONFIGURE RECRUITMENT Woluwe-Saint-Pierre €222,348 €95,224 48.2% -
IPXIP Uccle €191,948 €81,196 31.9% 1.3
Aquaqo Asse €220,323 €97,267 61.7% -

These companies have the same main activity as CARDIOMED: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €172,000 and €222,000, founded between 2001 and 2005.

Official details

Source: KBO
Status
Active since 17-04-2002Normal situation
Activity
Business and other management consultancyNACE 70200
Establishment unit
2.303.328.4451040 Etterbeek, since 01-01-2008
Financial year end
30 June
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 30-06-2025

≈ €170,000estimated
€208,391▼ 19.7%
Filing
Filed on 04-02-2026
Financials

Insights on CARDIOMED

CARDIOMED files the micro format. That format states no turnover. The gross margin fell from €126,012 in 2007 to €101,005 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CARDIOMED

What is the company number of CARDIOMED?
The company number of CARDIOMED is 0477.355.014. The VAT number is the same number with BE in front: BE 0477.355.014.
Where is CARDIOMED based?
The registered office is at Charles-Maurice Wiserplein 15, 1040 Etterbeek.Company details
What does CARDIOMED do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of CARDIOMED?
CARDIOMED is a private limited company (BV).
When was CARDIOMED founded?
CARDIOMED was founded on 17-04-2002.
Is CARDIOMED still active?
Yes, CARDIOMED is an active enterprise in the KBO register.
What is the turnover of CARDIOMED?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €101,005 and 123 comparable companies (NACE 70200). It probably lies between €140,000 and €200,000.Financials
Is CARDIOMED profitable?
In financial year 2025, CARDIOMED made a profit of €42,904.
Where can I find the annual accounts of CARDIOMED?
CARDIOMED filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CARDIOMED due?
CARDIOMED must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.